New research shows that many people with lupus may lack awareness or understanding of biologic therapies, or “biologics” – treatments that use substances made from living organisms like proteins and antibodies, versus conventional drugs, which are chemically made. Additionally, the study reveals both important similarities and differences in the way African-American and Caucasian people perceive these types of treatments. The findings emphasize the importance of patient education to help improve people’s understanding of biologics in order for them to make the best-informed treatment decision possible.

Researchers surveyed 676 people with lupus enrolled in the Georgians Organized Against Lupus (GOAL) Cohort and found that Caucasian people were much more likely to have heard of biologics than African-American respondents (53% versus 25%, respectively.) However, there were no

Read More At Article Source | Article Attribution